Cite
Szepeshazi K, Block NL, Schally AV. The use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancers. Horm Mol Biol Clin Investig. 2010;1(3):103-10doi: 10.1515/HMBCI.2010.018.
Szepeshazi, K., Block, N. L., & Schally, A. V. (2010). The use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancers. Hormone molecular biology and clinical investigation, 1(3), 103-10. https://doi.org/10.1515/HMBCI.2010.018
Szepeshazi, Karoly, et al. "The use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancers." Hormone molecular biology and clinical investigation vol. 1,3 (2010): 103-10. doi: https://doi.org/10.1515/HMBCI.2010.018
Szepeshazi K, Block NL, Schally AV. The use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancers. Horm Mol Biol Clin Investig. 2010 Jan 01;1(3):103-10. doi: 10.1515/HMBCI.2010.018. PMID: 25961976.
Copy
Download .nbib